Uptake of drugs into the intestinal lymphatics after oral administration

Advanced Drug Delivery Reviews

Volumn 25, Issue 1, 1997, Pages 71-89

  Porter, Christopher J H ^a   Charman, William N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Lipid formulations; Lipids; Lipoproteins; Lymph; Prodrugs

Indexed keywords

ABSORPTION; BLOOD VESSELS; LIPIDS; METABOLISM; VITAMINS;

INTESTINAL LYMPHATICS; LIPOPHILIC XENOBIOTICS; PRODRUGS;

PHARMACODYNAMICS;

2,2 DIMETHYL N (2,4,6 TRIMETHOXYPHENYL)DODECANAMIDE; CHLORAMBUCIL; CYCLOSPORIN; FLUOROURIDINE; HALOFANTRINE; LEVODOPA; LIPID; MEPITIOSTANE; NAFTIFINE; NAPROXEN; OLEIC ACID; POLYSORBATE 80; PROBUCOL; PRODRUG; PROPRANOLOL; SESAME SEED OIL; TRIOLEIN; VITAMIN; XENOBIOTIC AGENT;

DIGESTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG METABOLISM; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; INTESTINE ABSORPTION; INTESTINE LYMPH; LIPOPHILICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SYSTEMIC CIRCULATION;

EID: 0343051915     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00492-9     Document Type: Review

References (98)

1. Shiau, Y-F. (1981) Mechanism of intestinal fat absorption. Am. J. Physiol. 240, GI-G9.
2. Bisgaier, C.L. and Glickman, R.M. (1983) Intestinal synthesis, secretion and transport of lipoproteins. Annu. Rev. Physiol. 45, 625-636.
3. Thomson, A.B.R.. Keelan. M., Garg, M.L. and Clandinin, M.T. (1989) Intestinal aspects of lipid absorption: in review. Can. J. Physiol. Pharmacol. 67, 179-191.
4. Tso, P. (1994) Intestinal lipid absorption. In: L.R. Johnson (Chief Ed), Physiology of the Gastrointestinal Tract, Raven Press. New York, pp. 1867-1908.
5. Carey, M.C., Small. D.M. and Bliss, C.M. (1983) Lipid digestion and absorption. Annu. Rev. Physiol. 45, 651-677.
6. 2 and fatty acid for the digestion of dietary fat. Gastroenterology 78. 954-962.
7. Bernback. S., Blackberg L. and Hernell. O. (1989) Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase. Biochim. Biophys. Acta 1001, 286-293.
8. Hofmann, A.F. and Borgstrom, B. (1962) Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21. 43-50.
9. Hofmann, A.F. and Borgstrom, B. (1964) The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. 43, 247-257.
10. Staggers. J.E., Hernell. O., Stafford, R.J. and Carey, M.C. (1990) Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behaviour and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 29, 2028-2040.
11. Hernell, O., Staggers, J.E. and Carey. M.C. (1990) Physicalchemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 29, 2041-2056.
12. Borgstrom, B., Dahlqvist, A., Lundh, G. and Sjovall, J. (1957) Studies of intestinal digestion and absorption in the human. J Clin. Invest. 36, 1121-1136.
13. Van den Bosch, H., Postema, N.M., De Haas, G.H. and Van Deenen, L.L.M. (1965) On the positional specificity of phospholipase A from the pancreas. Biochim. Biophys. Acta 98, 657-659.
14. Hoffman, N.E. (1970) The relationship between uptake in vitro of oleic acid and micellar solubilization. Biochim. Biophys. Acta 196, 193-203.
15. Simmonds, W.J. ( 1972) The role of micellar solubilisation in lipid absorption. Aust. J. Exp. Biol. Med. Sci. 50, 403-421.
16. Westergaard, H. and Dietschy, J.M (1976) The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the mucosal cell. J. Clin. Invest. 58, 97-108.
17. Lucas, M.L., Schneider, W., Haberich, F.J. and Blair, J.A. (1975) Direct measurement by pH microelectrode of the pH microclimate in rat proximal jejunum. Proc. Royal Soc. B. 192, 39-48.
18. Shiau, Y-F., Fernandez, P., Jackson, M.J. and McMonagle, S. (1985) Mechanisms maintaining a low pH microclimate in the intestine. Am. J. Physiol. 248, G608-G619.
19. Shiau, Y-F. ( 1990) Mechanism of intestinal fatty acid uptake in the rat: the role of an acidic microclimate. J. Physiol. 421, 463-474.
20. Stremmel, W., Lotz, G., Strohmeyer, G. and Berk, P.D. (1985) Identification, isolation and partial characterisation of a fatty acid binding protein from rat jejunal microvillus membranes. J. Clin. Invest. 75, 1068-1076.
21. Stremmel, W. (1988) Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J. Clin. Invest. 82, 2001-2010.
22. Kiyasu, J.Y., Bloom. B. and Chaikoff. I.L. (1952) The portal transport of absorbed fatty acids. J. Biol. Chem. 199, 415-419.
23. McDonald. G.B. and Weidman. M. (1987) Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat. Q. J. Exp. Physiol. 72, 153-159.
24. McDonald. G.B., Saunders. D.R., Weidman, M. and Fisher. L. (1980) Portal venous transport of long-chain fatty acids absorbed from rat intestine. Am. J. Physiol. 239. GI41-G150.
25. Bugaut, M. and Carlier. H. (1987) Role of intestinal hydrolases, endogenous substrates and chyloportal partition in fat absorption. In: A. Kuksis (Ed.), Fat Absorption. Vol. 1. CRC Press, Boca Raton, pp. 197-232.
26. Davidson, N.O. (1994) Cellular and molecular mechanisms of small intestinal lipid transport. In: L.R. Johnson (Ed.), Physiology of the Gastrointestinal Tract. Raven Press, New York. 3rd ed, pp. 1909-1934.
27. Senior, J.R. and Isselbacher, K.J. (1962) Direct esterification of monoglycerides with palmityl coenzyme A by intestinal epithelial subcellular fractions. J Biol. Chem. 237, 1454-1459.
28. Johnson, J.M. (1976) Triglyceride biosynthesis in the intestinal mucosa. In: K. Rommel, H. Goebell and R. Bohmer (Eds.), Lipid absorption: biochemical and clinical aspects, MTP Press, Lancaster, pp. 85-94.
29. Zilversmit, D.B. (1965) The composition and structure of lymph chylomicrons in dog, rat and man. J. Clin. Invest. 44, 1610-1622.
30. Ueda, C.T., Lemaire, M., Gsell, G. and Nussbaumer, K. (1983) Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution to rats. Biopharm. Drug. Dispos. 4, 113-124.
31. Grimus, R.C. and Schuster, I. (1984) The role of the lymphatic transport in the enteral absorption of naftifine by the rat. Xenobiotica 14, 287-294.
32. Palin, K.J. and Wilson, C.J. (1984) The effect of different oils on the absorption of probucol in the rat. J. Pharm, Pharmacol. 36, 641-643.
33. Ichihashi, T., Kinoshita, H., Shimamura, K. and Yamada, H. (1991) Absorption and disposition of epithiosteroids in rats (1): route of administration and plasma levels of epitiostanol. Xenobiotica 21, 865-872.
34. Ichihashi, T., Kinoshita, H. and Yamada, H. (1991) Absorption and disposition of epithiosteroids in rats (2): avoidance of first-pass metabolism of mepitiostane by lymphatic absorption. Xenobiotica 21. 873-880.
35. Kuksis, A. (1987) Absorption of fat soluble vitamins. In: A. Kuksis (Ed.), Fat Absorption. Vol. 2. CRC Press, Boca Raton, pp. 65-86.
36. Porter. C.J.H., Charman. S.A. and Charman, W.N. (1996) Lymphatic transport of halofantrine in the triple-cannulated anaesthetized rat model: effect of lipid vehicle dispersion. J. Pharm. Sci. 85, 351-356.
37. Sieber, S.M. (1976) The lymphatic absorption of p,p-DDT and some structurally-related compounds in the rat. Pharmacology 14, 443-454.
38. Charman, W.N., Noguchi. T. and Stella, V.J. (1986) An experimental system designed to study the in situ intestinal lymphatic transport of drugs in anaesthetized rats. Int. J. Pharm. 33, 155-164.
39. Charman, W.N. and Stella, V.J. (1986) Effect of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT. Int. J. Pharm. 33, 165-172.
40. Laher. J.M., Rigler, M.W., Vetter, R.D., Barrowman, J.A. and Patton. J.S. (1984) Similar bioavailability and lymphatic transport of benzo(a)pyrene when administered to rats in different amounts of dietary fat. J. Lipid Res. 25, 1337-1342.
41. Busbee, D.L., Yoo. J.-S.H., Norman, J.O. and Joe, CO. (1985) Polychlorinated biphenyl uptake and transport by lymph and plasma components. Proc. Soc. Exp. Biol. Med. 179-116-122.
42. Bollman, J.L., Cava, J.C. and Grindley, J.H. (1948) Techniques for the collection of lymph from the liver, small intestine and thoracic duct of the rat. J. Lab. Clin. Med. 33, 1349-1352.
43. Reininger, E.J. and Saperstein, L.A. (1957) Effect of digestion on the distribution of blood flow in the rat. Science 126, 1176.
44. Charman, W.N. and Stella, V.J. (1986) Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. Int. J. Pharm. 34, 175-178.
45. Raub, T.J., Douglas, S.L., Melchior, G.W., Charman. W.N. and Morozowich, W. (1992) Methodologies for assessing intestinal lymphatic transport. In: W.N. Charman and V.J. Stella (Eds.), Lymphatic Transport of Drugs. CRC Press. Boca Raton, pp. 63-111.
46. Porter. C.J.H. and Charman. W.N. ( 1996) Model systems for intestinal lymphatic transport studies. In: R.T. Borchardt. P.L. Smith and G. Wilson (Eds.), Model systems for biopharmaceutical assessment of drug absorption and metabolism. Plenum Press, New York, pp. 85-102.
47. Stella, V.J. and Pochopin, N.L. (1992) Lipophilic prodrugs and the promotion of intestinal lymphatic drug transport. In: W.N. Charman and V.J. Stella (Eds.), Lymphatic Transport of Drugs. CRC Press, Boca Raton, pp. 181-210.
48. W.N. Charman and C.J.H. Porter (1996) Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug Deliv. Rev. 19, 149-169.
49. Dagett, P.R., Wheeler, M.J. and Naborro, J.D.N. (1978) Oral testosterone, a reappraisal. Hormone Res. 9, 121-129.
50. Tauber. U., Schroder, K., Dusterberg, B. and Matthes, H. (1986) Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone. Eur. J. Drug Metab. Pharmacokin. 11, 145-149.
51. Geelen, J., Coert. A., Meijer, R. and van der Vies, J. (1977) Comparison of the metabolism of testosterone undecanoate and testosterone in the gastrointestinal wall of the rat in vitro and in vivo. Acta Endocrinol. 86, 216-224.
52. Horst, H.J., Holte, W.J., Dennis, M., Coert, A., Geelen, J. and Voigt, K.D. (1976) Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wschr. 54, 875-879.
53. Noguchi, T., Charman, W.N. and Stella. V.J. (1985) Effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters. Int. J. Pharm. 24, 173-184.
54. Fernandez, E. and Borgstrom, B. (1990) Intestinal absorption of retinol and retinyl palmitate. Effects of tetrahydrolipstatin. Lipids 25, 549-552.
55. 2-α-tocopheryl esters in the rat. Lipids 10, 627-633.
56. Gallo-Torres, H.E. (1970) Obligatory role of bile for the intestinal absorption of vitamin E. Lipids 5. 379-384.
57. 2-α-tocopheryl nicotinate in the rat. Int. J. Vitam. Nutr. Res. 40, 505-514.
58. Hasegawa, J., Tomono, Y., Fujita, T., Sugiyama, K. and Hamamura, K. (1981) The effect of food on the absorption of α-tocopheryl nicotinate in beagle dogs and human volunteers. Int. J. Clin. Pharmacol. Ther. Tox. 19, 216-219.
59. Mishima. M., Kobayashi, S., Abe. S. and Yamato, C. (1990) Metabolic fate of indometacin farnesil, a prodrug of indomethacin: characteristic biotransformation of indometacin farnesil in rats. Xenobiotica 20, 135-146.
60. Ichihashi, T., Kinoshita, H., Takagishi, Y. and Yamada, H. (1992) Effect of oily vehicles on absorption of mepitiostane by the lymphatic system in rats. J. Pharm. Pharmacol. 44, 560-564.
61. Ichihashi, T., Kinoshita, H., Takagishi, Y. and Yamada, H. (1992) Effect of bile on absorption of mepitiostane by the lymphatic system in rats. J. Pharm. Pharmacol. 44, 566-569.
62. Ichihashi, T., Kinoshita, H., Takagishi, Y. and Yamada, H. (1991) Intrinsic lymphatic partition rate of mepitiostane, epitiostanol and oleic acid absorbed from rat intestine. Pharm. Res. 8, 1302-1306.
63. Sugihara, J., Furuuchi, S., Ando, H., Takashima, K. and Harigaya, S. (1988) Studies on the intestinal lymphatic absorption of drugs. II. Glyceride prodrugs for improving the lymphatic absorption of naproxen and nicotinic acid. J. Pharmacobio-Dyn. 11, 555-562.
64. Mizobe, M., Matsuda, S., Yoneyama, T. and Kohno, K. (1983) Evaluation of the bioavailability of hypolipidemic compound, LK-903. Chem. Pharm. Bull. 31, 2424-2431.
65. Sugihara, J. and Furuuchi, S. (1988) Lymphatic absorption of hypolipidemic compound l-O-[p-(myristyloxy)-αmethylcinnamoyl]glycerol (LK-903). J. Pharmacobio-Dyn. 11, 121-130.
66. Deverre, J.R., Loiseau, P., Couvreur, P., Letourneux, Y., Gayral, P. and Benoit, J.P. (1989) In vitro evaluation of filaricidal activity of GABA and 1.3-dipalmitoyl-2-(4-aminobutyryl)glycerol.HCl: a diglyceride prodrug. J. Pharm. Pharmacol. 41, 191-193.
67. Jacob, J.N., Hesse, G.W. and Shashoua, V.E. (1990) Synthesis, brain uptake and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor, γ-vinyl-GABA. J. Med. Chem. 33, 733-736.
68. Garzon-Abureh, A., Poupaert, J.H., Claesen, M. and Dumont, P. (1986) A lymphotropic prodrug of L-Dopa: Synthesis, pharmacological properties and pharmacokinetic behavior of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoyl]propane-l,2, 3-triol. J. Med. Chem. 29, 687-691.
69. Garzon-Abureh, A., Poupaert, J.H., Claesen, M., Dumont, P. and Atassi, G. (1983) 1,3-Dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent. J. Med. Chem. 26, 1200-1203.
70. Sakai. A., Mori, N., Shuto, S. and Suzuki, T. (1993) Deacylation-reacylalion cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoyl-phosphatidylfluorouridine in rats. J. Pharm. Sci. 82, 575-578.
71. Deverre, J.R., Loiseau, P., Puisieux, F., Gayral, P., Letourneux. Y., Couvreur, P. and Benoit, J.P. (1992) Synthesis of the orally macofilaricidal and stable glycerolipidic prodrug of melphalan, 1,3-dipalmitoyl-2-( 4′( bis( 2″-chloroethyl )amino)phenylalaninoyl)glycerol. Arzneim.-Forsch. 42, 1153-1156.
72. Deverre, J.R., Gulik, A., Letourneux, Y., Couvreur, P. and Benoit, J.P. (1991) Synthesis and aqueous organization of l,3-dipalmitoyl-2-(4-aminobutyryl)glycerol.HCl: a diglyceride prodrug. Chem. Phys. Lipids 59, 75-81.
73. Elkihel, L., Loiseau, P.M., Bourass, J., Gayral, P. and Letourneux, Y. (1994) Synthesis and orally macrofilaricidal evaluation of niclosamide lymphotropic prodrugs. Arzneim.Forsch. 44, 1259-1264.
74. Charman, W.N. (1992) Lipid vehicle and formulation effects on intestinal lymphatic drug transport. In: W.N. Charman and V.J. Stella (Eds.), Lymphatic Transport of Drugs. CRC Press, Boca Raton, pp. 63-111.
75. Muranishi, S. (1991) Drug targeting towards the lymphatics. Adv. Drug. Res. 21, 1-38.
76. Fukui, E., Kurohara, H., Kareyu, A., Kurisaki, Y., Nakayaman T. and Kimura, T. (1989) Enhancing effect of medium-chain triglycerides on intestinal absorption of D-αtocopherol acetate from lecithin-dispersed preparations in the rat, J. Pharmacobio-Dyn. 12, 80-86.
77. Fernandez, E. and Borgstrom, B. (1989) Effects of tetrahydrolipistatin, a lipase inhibitor on absorption of fat from the rat intestine. Biochim. Biophys. Acta. 1001, 249-255.
78. Noguchi, T., Charman, W.N. and Stella, V.J. (1985) The effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters. Int. J. Pharm. 24, 173-184.
79. Liu, H., Adachi, I., Horkoshi, I. and Ueno, M. (1991) Promotion of intestinal drug absorption by milk fat globule membrane. Yakugaku Zasshi 111, 510-514.
80. Adachi, I., Liu, H., Horkoshi, I. and Ueno, M. (1993) Possibility of lymphatic absorption of epidermal growth factor from intestine. Yakugaku Zasshi 113, 256-263.
81. Moriwaki, T., Yoshikawa, H., Takada, K. and Muranishi, S. (1990) DDS with MFGM (milk fat globule membrane): gastrointestinal absorption of vitamin A acetate. Yakuzaikaku 50, 263-267.
82. Honda, T., Okamolo, M., Maeda. M., Kawagoshi, T., Nihonmatsu, H., Yamashita, I., Yoshida, M., Tazawa. K. and Fujimaki, M. (1992) DDS with MFGM (milk fat globule membrane): intestinal absorption of MFGM-insulin emulsion. Drug Del. Sys. 7, 43-46.
83. Liu, H-X., Adachi, I., Horikoshi. I. and Ueno, M. (1995) Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane. Int. J. Pharm. 118, 55-64.
84. Hauss, D.J., Mehta, S. and Radebaugh, G.W. (1994) Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach. Int. J. Pharm. 108. 85-93.
85. Porter, C.J.H., Charman, S.A., Humberstone, A.J. and Charman. W.N. ( 1996) Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion. J. Pharm. Sci. 85, 357-361.
86. Nishigaki, R., Awazu, S., Hanano, M. and Fuwa, T. (1976) The effect of dosage form on absorption of vitamin A into lymph. Chem. Pharm. Bull. 24, 3207-3211.
87. Takada, K., Yoshimura, H., Yoshikawa, H., Muranishi, S., Yasumura, T. and Oka, S. (1986) Enhanced lymphatic delivery of cyclosporin A by solubilisers and intensified immunosuppressive activity against mice skin allograft. Pharm. Res. 3, 48-51.
88. White, D.G., Story, M.J. and Barnwell, S.G. (1991) An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol. Int. J. Pharm. 69, 169-174.
89. Barnwell, S.G., Laudanski, T., Story, M.J., Mallinson, C.B., Harris, R.J., Cole, S.K., Keating, M. and Attwood, D. (1992) Improved oral bioavailability of propranolol in healthy human volunteers using a liver bypass drug delivery system containing oleic acid. Int. J. Pharm. 88, 423-432.
90. Barnwell, S.G., Gauci, L., Harris, R.J., Attwood, D., Littlewood, G., Guard, P., Pickup, M.E. and Barrington, P. (1993) Greatly enhanced oral bioavailability of propranolol using the HALO™ liver bypass drug delivery system. International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, pp. 306-309.
91. Green, P.G. and Hadgraft, J. (1987) Facilitated transfer of cationic drugs across a lipoidal membrane. Int. J. Pharm. 37, 251-255.
92. Davidson, N.O., Drewek, M.J., Gordon, J.I. and Elovson, J. (1988) Rat intestinal apolipoprotein B gene expression. Evidence for integrated regulation in bile salt, fatty acid and phospholipid flux. J. Clin. Invest. 82, 300-308.
93. Pullinger, C.R., North. J.F., Teng, B.B., Rifici, V.A., Ronchild de Brito, A.E. and Scott, J. (1989) The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin and insulin and measurement of the mRNA half life. J. Lipid Res. 30, 1065-1077.
94. Homan, R., Grossman, J.E. and Pownall, H.J. (1991) Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells. J. Lipid. Res. 32, 231-241.
95. Dashti, N., Smith, E.A. and Alanpovic, P. (1990) Increased production of apoprotein B and its lipoprotein by oleic acid in Caco2 cells. J. Lipid Res. 31, 113-123.
96. Moberly, J.B., Cole, T.G., Alpers. D.H. and Schonfield, G. (1990) Oleic acid stimulation of apolipoprotein B secretion from HepG2 cells and Caco2 cells occurs post-transcriptionally. Biochim. Biophys. Acta 1042, 70-80.
97. Irwin, W.J. and Belaid, K.A. (1987) Drug delivery by ion exchange. Physicochemical properties of ester prodrugs of propranolol. Drug. Dev. Ind. Pharm. 13, 2033-2045.
98. Tucker, G. (1993) Drug delivery: lymphing along? The Lancet 341, 1314-1315.